A multicenter phase II study of TSU-68, an oral multiple tyrosine kinase inhibitor, in combination with docetaxel in metastatic breast cancer patients with anthracycline resistance.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Hiroji Iwata Masakazu Toi Kenichi Inoue |
| Publication date | March 2, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |